Enzymatic Capsulotomy for Shoulder Adhesive Capsulitis

Background

Adhesive capsulitis of the shoulder, more commonly known as frozen shoulder, results in painful limitation of shoulder motion. It can arise idiopathically or after trauma. The current standard of care is a long course of painful physical therapy to restore shoulder motion. Failing that, patients? often undergo surgical procedures, such as manipulation under general anesthesia, arthroscopy, or even open shoulder surgery.

Technology

Patients suffering from frozen shoulder may be able to avoid a long course of painful physical therapy, manipulation under general anesthesia, arthroscopy or open shoulder surgery. Instead, researchers from Stony Brook University have invented a less invasive and more cost-effective collagenase injection, or short series of collagenase injections, which may provide relief from this painful and debilitating condition in a timelier manner.

Advantages

Less invasive - More cost-effective - Quicker relief

Application

Treatment of frozen shoulder

Patent Status

Patented

Stage Of Development

Undergoing FDA approval. PCT Publication No. US 2015-0174216.

Licensing Potential

Licensing

Licensing Status

Exclusive License - All Fields.

Additional Info

Additional Information:

https://stonybrook.technologypublisher.com/files/sites/7504---enzymatic-capsulotomy-for-shoulder-adhesive-capsulitis.jpg Source: Jesper Aggergaard, unsplash.com/photos/CEM52sAHR80, Unsplash Licence
Patent Information:
Case ID: R7504
For Information, Contact:
Donna Tumminello
Assistant Director
State University of New York at Stony Brook
6316324163
donna.tumminello@stonybrook.edu
Inventors:
Marie Badalamente
Edward Wang
Keywords:
Collagenase Injection
Frozen shoulder
Nonoperative Therapy
Technologies